Boston Scientific’s $850 Million Acquisition of Relievant MedSystems

Faegre Drinker advised Boston Scientific, and Latham & Watkins advised Relievant MedSystems on the deal.Boston Scientific Corporation (NYSE: BSX) announced it has entered into a definitive…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Pietro Martinoia

This content is for Standard 1 Year members only.
Login Join Now